Louis Frederic Diehl, MD

Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 5170 Hosp South, Durham, NC 27710
Phone (919) 681-7648
Email address louis.diehl@duke.edu

Research interests include Hodgkin disease, non-Hodgkin lymphomas, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplasia.

In Their Words

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Walter Reed Army Medical Center, 1978 - 1981
  • Medical Resident, Medicine, Walter Reed Army Medical Center, 1975 - 1978
  • M.D., Georgetown University, 1975

Publications

Hudson, KE, Rizzieri, D, Thomas, SM, LeBlanc, TW, Powell, Z, Diehl, L, Moore, JO, DeCastro, C, and Beaven, AW. "Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study." British journal of haematology (February 21, 2018). (Letter)

PMID
29468651
Full Text

Mylam, KJ, Kostakoglu, L, Hutchings, M, Coleman, M, Lamonica, D, Czuczman, MS, Diehl, LF, Nielsen, AL, Jensen, P, Loft, A, Hendel, HW, Iyer, V, Leppä, S, Jyrkkiö, S, Holte, H, Eriksson, M, Gillstrøm, D, Hansen, PB, Seppänen, M, Hjorthaug, K, Brown, PDN, and Pedersen, LM. "(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study." Leukemia & lymphoma 56, no. 7 (July 2015): 2005-2012.

PMID
25330442
Full Text

Torok, JA, Wu, Y, Prosnitz, LR, Kim, GJ, Beaven, AW, Diehl, LF, and Kelsey, CR. "Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma." International journal of radiation oncology, biology, physics 92, no. 1 (May 2015): 54-59.

PMID
25863754
Full Text

Beaven, AW, and Diehl, LF. "Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma." Hematology. American Society of Hematology. Education Program 2015 (January 2015): 550-558.

PMID
26637771
Full Text

Boyle, J, Beaven, AW, Diehl, LF, Prosnitz, LR, and Kelsey, CR. "Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy." Oncology (Williston Park, N.Y.) 28, no. 12 (December 2014): 1074-1084.

PMID
25510806
Scholars@Duke

Hutchings, M, Kostakoglu, L, Zaucha, JM, Malkowski, B, Biggi, A, Danielewicz, I, Loft, A, Specht, L, Lamonica, D, Czuczman, MS, Nanni, C, Zinzani, PL, Diehl, L, Stern, R, and Coleman, M. "In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 32, no. 25 (September 2014): 2705-2711.

PMID
25071108
Full Text

Brander, D, Rizzieri, D, Gockerman, J, Diehl, L, Shea, TC, Decastro, C, Moore, JO, and Beaven, A. "Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma." Leukemia & lymphoma 54, no. 12 (December 2013): 2627-2630.

PMID
23488610
Full Text

Held, LA, Rizzieri, D, Long, GD, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Horwitz, ME, Chao, NJ, and Gasparetto, C. "A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma." Cancer Invest 31, no. 3 (March 2013): 172-176.

PMID
23406188
Full Text

Morris, TA, DeCastro, CM, Diehl, LF, Gockerman, JP, Lagoo, AS, Li, Z, Moore, JO, Rizzieri, DA, and Rao, AV. "Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia." Leuk Res 37, no. 1 (January 2013): 28-31.

PMID
23046833
Full Text

DiLillo, DJ, Weinberg, JB, Yoshizaki, A, Horikawa, M, Bryant, JM, Iwata, Y, Matsushita, T, Matta, KM, Chen, Y, Venturi, GM, Russo, G, Gockerman, JP, Moore, JO, Diehl, LF, Volkheimer, AD, Friedman, DR, Lanasa, MC, Hall, RP, and Tedder, TF. "Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function." Leukemia 27, no. 1 (January 2013): 170-182.

PMID
22713648
Full Text

Pages